RBC Capital Reaffirms Their Buy Rating on Boston Scientific (BSX)
In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with ...
RBC Capital Remains a Buy on Boston Scientific (BSX)
In a report released on January 6, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Boston Scientific (BSX – Research Report), ...
RBC Capital holds Boston Scientific stock Outperform rating
In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with ...
Capital Investment Advisors LLC Increases Stake in Boston Scientific Co. (NYSE:BSX)
Capital Investment Advisors LLC raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 12.2% in ...
TD Cowen maintains Boston Scientific buy rating, $110 target
TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...
medtechdive11d
5 medtech trends to watch in 2025
After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...
The TRADE4d
RBC Capital Markets names new head of European and Asian product, multi-asset agency solutions
RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager ...
Investing5d
RBC downgrades Anglo and Antofagasta on valuation concerns and market pressures
Investing.com -- RBC Capital Markets has downgraded both Anglo American (JO:AGLJ) plc and Antofagasta (LON:ANTO) plc to "underperform," citing valuation concerns, rising financial pressures ...